CORT CORCEPT THERAPEUTICS INC

NEUTRAL Impact: 3/10 Insider Cluster (2 insiders)
Horizon days Filed May 29, 2026 Processed 4d 2h ago
Insider cluster: 2 insiders, $3.9M total
Latest settled — T+1d
CORT ▲ +1.08% at T+1d
NEUTRAL call ✓ call won +1.08% · α vs SPY +0.93% · entry $70.44 → $71.20
Next anchor: T+5d due yesterday
Currently $72.62 · +3.09% from $70.44 entry
Entry anchored
May 29, 03:59 PM ET
via Databento tick
T+1d
+1.08%
call +1.08% · α +0.93%
$71.20
settled 5d ago
T+5d
call — · α —
due yesterday
T+20d
call — · α —
in 23d
T+60d
call — · α —
in 3mo

Price Chart

Loading chart...

Executive Summary

Two Corcept Therapeutics insiders sold a combined $3.89M in open-market sales on May 27, 2026, with CEO Belanoff also gifting 300,000 shares (non-cash) on May 29. The sales represent ~0.05% of the $7.6B market cap, well below the 0.1% materiality threshold, and are likely routine liquidity/vesting-related transactions rather than a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$3.9M
Insiders
2

Actionable Insight

The insider sales are immaterial relative to market cap and likely driven by routine diversification or tax planning. The CEO's gift and director's gift are non-cash events with no market signal. Monitor upcoming earnings for any fundamental changes, but this cluster alone does not warrant a bearish read.

Key Facts

  • Maduck Sean sold 54,575 shares at $65.37 for $3.57M on May 27
  • Lyon Joseph Douglas sold 5,000 shares at $65.00 for $325K on May 27
  • CEO Belanoff gifted 300,000 shares at $0 (non-cash) on May 29
  • CEO Belanoff also sold 12,837 shares at $69.74 for $895K on June 1
  • Total open-market sales in cluster: $3.89M, or ~0.05% of $7.6B market cap
  • Director Wilson gifted 892,056 shares at $0 (non-cash) on May 27
  • Maduck also exercised 75,000 derivative shares at $8.27 for $620,250 (non-cash exercise)

Financial Impact

Open-market sales of $3.89M represent ~0.05% of market cap — trivial relative to company size

dilution

Risk Factors

  • CEO's June 1 sale at higher price ($69.74) could indicate incremental selling, but still small relative to his holdings
  • No insider buying to offset the selling pattern

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (12 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CORT-1780430796567
12 reports for CORT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CORT — sortable, filterable
Type Now
Jun 4, 2026
2d ago
Insider Cluster
NEUTRAL ★ 3/10
awaiting T+1
Jun 3, 2026
2d ago
Insider Cluster
NEUTRAL ★ 3/10
awaiting T+1
Jun 3, 2026
2d ago
Insider Cluster
BEARISH ★ 5/10
awaiting T+1
Jun 3, 2026
2d ago
Insider Cluster
NEUTRAL ★ 4/10
awaiting T+1
Jun 3, 2026
3d ago
8-K
BULLISH ★ 6/10
$72.65 $74.89▲ +3.08%▲ +2.68%$72.62 (−0.04%)
Jun 2, 2026
4d ago
Insider Cluster
NEUTRAL ★ 3/10
$72.65 $74.89▲ +3.08%▲ +2.68%$72.62 (−0.04%)
May 29, 2026
8d ago
Insider Cluster
NEUTRAL ★ 3/10
$70.44 $71.20▲ +1.08%▲ +0.93%$72.62 (+3.09%)
May 29, 2026
8d ago
Insider Cluster
NEUTRAL ★ 3/10
awaiting T+1
May 1, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$51.42 $51.60▲ +0.35%▲ +0.69%$72.62 (+41.23%)
Mar 20, 2026
11w ago
Insider Cluster
NEUTRAL ★ 3/10
$34.64 $33.63▼ −2.92%▼ −4.02%$72.62 (+109.64%)
Showing 10 of 12

US Market Status

Market Closed — Opens Mon (14h 53m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access